MIRA Pharmaceuticals, Inc.
- MIRA
- NASDAQ
- Drug manufacturers
- Synthetic THC Analog
- Clinical-Stage Biopharma
- Cannabinoid Therapeutics
$0.64
Today +1.55%Quote Oct 19, 2026, 07:40 PM UTC
−16.73%over the last month
Max drawdown −30.2%From 1-month high −30.2%3 months −31.3%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About MIRA Pharmaceuticals
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic tetrahydrocannabinol (THC) analog.
Sector
Healthcare
Industry
Drug manufacturers
Exchange
NASDAQ
Employees
2
Market value
$27.0M
Quote Oct 19
Floor
$0.62
3.8% below price
Resistance
$0.65
1.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MIRAPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free